Corporate VC · Israel
Business models
biotech_therapeutics
Customer segments
Patients, Healthcare providers, Pharmaceutical partners
Geography
US, Europe, UK, Israel
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Dexcel Pharma writes strategic capital from an operating company. The thesis is usually narrower than a financial fund, but the value-add (customer intros, distribution, technical resources) is often what closes the round when the cap table is competitive. VCboom tracks Dexcel Pharma alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Dexcel Pharma is one of them — and we'll tell you exactly where they sit in your top 100.